There were 1,806 press releases posted in the last 24 hours and 312,263 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Oxidien Pharmaceuticals Announces Favorable Response from FDA on Proposed Development Plan

TO:
Helena Cowley
Oxidien Pharmaceuticals, LLC
+1 352-672-5320

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image